Loading
IA
Immunicum AB Stock: price and insider trades · Sweden
ISIN SE0010600551SE·
No insider purchase over the last 90 days. The latest, by Erik Manting, was filed 23 May 2022.
Immunicum AB: what insiders have been doing
Immunicum AB is a listed company. Filings by its managers are published through Finansinspektionen. The past year has been quiet: not a single insider filing for Immunicum AB. The previous disclosure was published on 23 May 2022.
Our records for Immunicum AB go back to 2018, with 29 purchases and 1 sale on the open market in total.
Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Insider Decl.
30
Thresholds
n/a
Buy Volume
€386,545
29 ops. · all time
Sell Volume
€306
1 ops. · all time
Last declaration on 23 May 2022
Declarations30 total
62,941 shares@ SEK 2.154.2% of flowAktieISIN SE0005003654FI:csv-d431ba3a8c910140c84e
Canonical exit: 17 Aug 2022 (T+90)
37,059 shares@ SEK 2.332.7% of flowAktieISIN SE0005003654FI:csv-d47b962a8c17404d505b
Canonical exit: 18 Aug 2022 (T+90)
100,000 shares@ SEK 2.159AktieISIN SE0005003654FI:csv-ba156e0afdb992463b1a
Canonical exit: 17 Aug 2022 (T+90)
84,000 shares@ SEK 2.52AktieISIN SE0005003654FI:csv-28878dbc1437942461c2
Canonical exit: 24 May 2022 (T+90)
10,000 shares@ SEK 2.565AktieISIN SE0005003654FI:csv-40064f5721594f6bf666
Canonical exit: 24 May 2022 (T+90)
10,000 shares@ SEK 2.3639AktieISIN SE0005003654FI:csv-1cd4c0eebcc5d431ab09
Canonical exit: 23 May 2022 (T+90)
20,000 shares@ SEK 2.3736AktieISIN SE0005003654FI:csv-9f4d90772fdf4f5090b0
Canonical exit: 23 May 2022 (T+90)
1,000 shares@ SEK 3.20AktieISIN SE0005003654FI:csv-b0eac9161be1665ece46
Canonical exit: 21 Mar 2022 (T+90)
1,000 shares@ SEK 3.16AktieISIN SE0005003654FI:csv-a98718ab2346e5c94d44
1,250 shares@ SEK 3.20AktieISIN SE0005003654FI:csv-3d5651188b11066f3d58
Canonical exit: 21 Mar 2022 (T+90)
10,000 shares@ SEK 3.24AktieISIN SE0005003654FI:csv-25d6dfb5534fbdec2742
Canonical exit: 21 Mar 2022 (T+90)
4,005 shares@ SEK 3.24AktieISIN SE0005003654FI:csv-13e9966fd657443f1673
Canonical exit: 21 Mar 2022 (T+90)
500 shares@ SEK 3.23AktieISIN SE0005003654FI:csv-05a627e1cc6fcf22c7de
Canonical exit: 21 Mar 2022 (T+90)
5,230 shares@ SEK 3.24AktieISIN SE0005003654FI:csv-94d708ccf51261171ba1
Canonical exit: 21 Mar 2022 (T+90)
3,316 shares@ SEK 3.15AktieISIN SE0005003654FI:csv-524abbf7edaea8408a93
Canonical exit: 21 Mar 2022 (T+90)
170 shares@ SEK 3.23AktieISIN SE0005003654FI:csv-e54ce21be9442c08a52d
Canonical exit: 21 Mar 2022 (T+90)
6,684 shares@ SEK 3.15AktieISIN SE0005003654FI:csv-4f05d484c2a717cd1fc6
Canonical exit: 21 Mar 2022 (T+90)
8,750 shares@ SEK 3.20AktieISIN SE0005003654FI:csv-e46458a3a31db77b5fd8
Canonical exit: 21 Mar 2022 (T+90)
10,000 shares@ SEK 3.20AktieISIN SE0005003654FI:csv-f2a0e9c2c248630dec2f
Canonical exit: 21 Mar 2022 (T+90)
30 shares@ SEK 3.22AktieISIN SE0005003654FI:csv-daf8fb7c162aeee17233
Canonical exit: 21 Mar 2022 (T+90)
10 shares@ SEK 3.23AktieISIN SE0005003654FI:csv-4566462ba351c57648e8
Canonical exit: 21 Mar 2022 (T+90)
55 shares@ SEK 3.23AktieISIN SE0005003654FI:csv-c2e467be0748dde72614
Canonical exit: 21 Mar 2022 (T+90)
79,650 shares@ SEK 3.17AktieISIN SE0005003654FI:csv-604a3d5d05b892c2e382
Canonical exit: 21 Mar 2022 (T+90)
534,000 shares@ SEK 4.58AktieISIN SE0005003654FI:csv-04b7c490a1be709354c7
Canonical exit: 15 Sept 2021 (T+90)
25,000 shares@ SEK 6.00AktieISIN SE0005003654FI:csv-14b141164ac5963bedcd
Canonical exit: 1 Jul 2021 (T+90)
25 of 30 declarations
About Immunicum AB
Immunicum AB is a Swedish biopharmaceutical company focused on developing immunological treatments for cancer. It is listed on the Stockholm Stock Exchange.
